Cormorant Asset Management, Llc
Affiliations
- Other at Design Therapeutics Inc. (DSGN), 2021-04-01
- Other at Prometheus Biosciences Inc. (RXDX), 2021-03-18
- Other at Bioatla Inc. (BCAB), 2020-12-22
- Other at Olema Pharmaceuticals Inc. (OLMA), 2020-11-23
- Other at Atea Pharmaceuticals Inc. (AVIR), 2020-11-05
- Other at Akouos Inc. (AKUS), 2020-07-02
- Other at Avidity Biosciences Inc. (RNA), 2020-06-18
- Other at Turning Point Therapeutics Inc. (TPTX), 2019-08-12
- Large Shareholder at Axonics Modulation Technologies Inc. (AXNX), 2018-11-02
- Large Shareholder at Constellation Pharmaceuticals Inc (CNST), 2018-07-20
- Large Shareholder at Kezar Life Sciences Inc. (KZR), 2018-06-27
- Large Shareholder at Kiniksa Pharmaceuticals Ltd. (KNSA), 2018-05-31
- Large Shareholder at Proteostasis Therapeutics Inc. (PTI), 2017-12-18
- Large Shareholder at Apellis Pharmaceuticals Inc. (APLS), 2017-11-14
- Large Shareholder at Clearside Biomedical Inc. (CLSD), 2016-06-13
- Large Shareholder at Cellectar Biosciences Inc. (CLRB), 2014-09-05
Insider Trading: Purchases See All
| Company | Symbol | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|---|
| DSGN | $20.00 | 750,000 | Other | 5,114,844 | 2021-03-30 | Filing | |
| RXDX | $19.00 | 375,000 | Other | 2,223,022 | 2021-03-16 | Filing | |
| BCAB | $18.00 | 800,000 | Other | 2,292,060 | 2020-12-18 | Filing | |
| OLMA | $19.00 | 425,000 | Other | 3,270,544 | 2020-11-23 | Filing | |
| AKUS | $17.00 | 290,000 | Other | 789,989 | 2020-06-30 | Filing |
Insider Trading: Sales See All